Literature DB >> 11950776

Current progress on esterases: from molecular structure to function.

Tetsuo Satoh1, Palmer Taylor, William F Bosron, Sonal P Sanghani, Masakiyo Hosokawa, Bert N La Du.   

Abstract

This article reports on a symposium sponsored by the American Society for Pharmacology and Experimental Therapeutics and held at the April 2001 Experimental Biology meeting. Current developments in molecular-based studies into the structure and function of cholinesterases, carboxylesterases, and paraoxonases are described. This article covers mechanisms of regulation of gene expression of the various esterases by developmental factors and xenobiotics, as well as the interplay between physiological and chemical regulation of enzyme activity.

Mesh:

Substances:

Year:  2002        PMID: 11950776     DOI: 10.1124/dmd.30.5.488

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  58 in total

1.  Prediction and in vitro evaluation of selected protease inhibitor antiviral drugs as inhibitors of carboxylesterase 1: a potential source of drug-drug interactions.

Authors:  Jenna A Rhoades; Yuri K Peterson; Hao-Jie Zhu; David I Appel; Charles A Peloquin; John S Markowitz
Journal:  Pharm Res       Date:  2011-12-09       Impact factor: 4.200

2.  Activity-based protein profiling identifies a host enzyme, carboxylesterase 1, which is differentially active during hepatitis C virus replication.

Authors:  David R Blais; Rodney K Lyn; Michael A Joyce; Yanouchka Rouleau; Rineke Steenbergen; Nicola Barsby; Lin-Fu Zhu; Adrian F Pegoraro; Albert Stolow; David L Tyrrell; John Paul Pezacki
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

3.  Mammalian carboxylesterase 3: comparative genomics and proteomics.

Authors:  Roger S Holmes; Laura A Cox; John L VandeBerg
Journal:  Genetica       Date:  2010-04-28       Impact factor: 1.082

Review 4.  Prediction of hepatic clearance in human from in vitro data for successful drug development.

Authors:  Masato Chiba; Yasuyuki Ishii; Yuichi Sugiyama
Journal:  AAPS J       Date:  2009-04-30       Impact factor: 4.009

Review 5.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

Review 6.  The role of human carboxylesterases in drug metabolism: have we overlooked their importance?

Authors:  S Casey Laizure; Vanessa Herring; Zheyi Hu; Kevin Witbrodt; Robert B Parker
Journal:  Pharmacotherapy       Date:  2013-02       Impact factor: 4.705

7.  Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.

Authors:  S Casey Laizure; Robert B Parker; Vanessa L Herring; Zhe-Yi Hu
Journal:  Drug Metab Dispos       Date:  2013-11-08       Impact factor: 3.922

8.  Undesired versus designed enzymatic cleavage of linkers for liver targeting.

Authors:  Srinivas R Chirapu; Jonathan N Bauman; Heather Eng; Theunis C Goosen; Timothy J Strelevitz; Subhash C Sinha; Robert L Dow; M G Finn
Journal:  Bioorg Med Chem Lett       Date:  2014-01-08       Impact factor: 2.823

9.  Baboon carboxylesterases 1 and 2: sequences, structures and phylogenetic relationships with human and other primate carboxylesterases.

Authors:  Roger S Holmes; Jeremy P Glenn; John L VandeBerg; Laura A Cox
Journal:  J Med Primatol       Date:  2009-02       Impact factor: 0.667

10.  Amino acid ester prodrugs of floxuridine: synthesis and effects of structure, stereochemistry, and site of esterification on the rate of hydrolysis.

Authors:  Balvinder S Vig; Philip J Lorenzi; Sachin Mittal; Christopher P Landowski; Ho-Chul Shin; Henry I Mosberg; John M Hilfinger; Gordon L Amidon
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.